Observational studyThe Journal of international medical research2025
Ten-year experience with transcatheter mitral valve repair using the MitraClip system in Vietnam: A multicenter observational study.
Observational study in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivesNumerous studies have demonstrated the safety and efficacy of percutaneous MitraClip transcatheter interventional therapy in treating mitral regurgitation. This study reports the largest series of outcomes in Vietnamese patients who underwent the MitraClip procedure.Methods and resultsBetween September 2014 and December 2024, 23 patients (20 males and 3 females; mean age, 66.3 ± 10.2 years) underwent the MitraClip procedure at five hospitals across Vietnam. Key findings included a high procedural success rate, with 91.3% of patients receiving successful implantations. Postprocedural complications were observed in 33.3% of patients. During the 30-day follow-up, two patients (9.5%) were readmitted; however, no mortality was reported. All patients achieved a mitral regurgitation grade of ≤2+, and 92.9% showed improvement to New York Heart Association Class I/II within 30 days postprocedure.ConclusionsMulticenter data from hospitals across Vietnam indicate that the MitraClip procedure is effective in reducing mitral regurgitation and demonstrate favorable short-term safety outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.